Hepatitis E virus (HEV) superinfection has a significant impact on a natural course of chronic hepatitis B (CHB) patients with underlying chronic liver disease (CLD). These patients usually present with increased symptoms, rapid decompensation to liver failure, and increased mortality. An increasing rate of HEV infections worldwide with uncertainties in its prevention and treatment raises a great concern to this group of patients. Therefore, in this article, we reviewed recent studies describing the epidemiological patterns of HEV and Hepatitis B virus (HBV), both mono and dual infections. We also reviewed the literature on clinical interaction among HBV/HEV-superinfected patients with CLD and the potential preventive strategies.
第一作者单位:[1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept & Inst Infect Dis,Wuhan,Hubei,Peoples R China[2]Catholic Univ Hlth & Allied Sci, Weill Sch Med, Dept Internal Med, Mwanza, Tanzania
通讯作者:
推荐引用方式(GB/T 7714):
Kilonzo Semvua B.,Gunda Daniel,Ning Qing,et al.Where Hepatitis B and Hepatitis E Meet: Epidemiological and Clinical Aspects[J].HEPATITIS MONTHLY.2019,19(10):doi:10.5812/hepatmon.93840.
APA:
Kilonzo, Semvua B.,Gunda, Daniel,Ning, Qing&Han, Meifang.(2019).Where Hepatitis B and Hepatitis E Meet: Epidemiological and Clinical Aspects.HEPATITIS MONTHLY,19,(10)
MLA:
Kilonzo, Semvua B.,et al."Where Hepatitis B and Hepatitis E Meet: Epidemiological and Clinical Aspects".HEPATITIS MONTHLY 19..10(2019)